{rfName}

Indexed in

License and use

Citations

14

Altmetrics

Analysis of institutional authors

Rodríguez-Espinosa DAuthorQuintana LfAuthorBlasco, MAuthorRivera MvCorresponding Author

Share

February 4, 2022
Publications
>
Working Papers
No

Cloudy fluid, cloudy diagnosis

Publicated to:Peritoneal Dialysis International. 42 (6): 643-646 - 2022-01-01 42(6), DOI: 10.1177/08968608211072345

Authors: Risco-Zevallos JD, Piñeyroa J, Rodríguez-Espinosa D, Garrote M, Gaya A, Broseta JJ, Quintana LF, Blasco M, Rivera MV

Affiliations

Hematology Department, Hospital Clínic de Barcelona, Spain. - Author
Hematopathology Unit, Pathology Department, Hospital Clínic de Barcelona, Spain. - Author
Hosp Clin Barcelona, Hematol Dept, Barcelona, Spain - Author
Hosp Clin Barcelona, Nephrol & Renal Transplantat Dept, Villarroel 170, Barcelona 08036, Spain - Author
Hosp Clin Barcelona, Pathol Dept, Hematopathol Unit, Barcelona, Spain - Author
Nephrology and Renal Transplantation Department, Hospital Clínic de Barcelona, Spain. - Author
See more

Abstract

Here, we report a case of a patient with cloudy effluent that was initially diagnosed as bacterial peritonitis. The persistence of a cloudy effluent despite antibiotic therapy led to an extensive peritoneal dialysis (PD) effluent analysis, with the final diagnosis being high-grade B-cell lymphoma. This case will increase the awareness of this rare presentation of a lymphoproliferative disorder reminding clinicians to consider this diagnosis as a part of the differential diagnosis PD effluent.

Keywords

lymphomapatientperitoneal dialysisCloudy effluentLymphomaPeritoneal dialysisPeritonitis

Quality index

Bibliometric impact. Analysis of the contribution and dissemination channel

The work has been published in the journal Peritoneal Dialysis International due to its progression and the good impact it has achieved in recent years, according to the agency WoS (JCR), it has become a reference in its field. In the year of publication of the work, 2022, it was in position 40/88, thus managing to position itself as a Q2 (Segundo Cuartil), in the category Urology & Nephrology. Notably, the journal is positioned en el Cuartil Q2 para la agencia Scopus (SJR) en la categoría Nephrology.

From a relative perspective, and based on the normalized impact indicator calculated from World Citations provided by WoS (ESI, Clarivate), it yields a value for the citation normalization relative to the expected citation rate of: 1.98. This indicates that, compared to works in the same discipline and in the same year of publication, it ranks as a work cited above average. (source consulted: ESI Nov 14, 2024)

Specifically, and according to different indexing agencies, this work has accumulated citations as of 2025-07-16, the following number of citations:

  • WoS: 13

Impact and social visibility

From the perspective of influence or social adoption, and based on metrics associated with mentions and interactions provided by agencies specializing in calculating the so-called "Alternative or Social Metrics," we can highlight as of 2025-07-16:

  • The use, from an academic perspective evidenced by the Altmetric agency indicator referring to aggregations made by the personal bibliographic manager Mendeley, gives us a total of: 4.
  • The use of this contribution in bookmarks, code forks, additions to favorite lists for recurrent reading, as well as general views, indicates that someone is using the publication as a basis for their current work. This may be a notable indicator of future more formal and academic citations. This claim is supported by the result of the "Capture" indicator, which yields a total of: 5 (PlumX).

With a more dissemination-oriented intent and targeting more general audiences, we can observe other more global scores such as:

  • The Total Score from Altmetric: 3.95.
  • The number of mentions on the social network X (formerly Twitter): 6 (Altmetric).

Leadership analysis of institutional authors

There is a significant leadership presence as some of the institution’s authors appear as the first or last signer, detailed as follows: Last Author (Vera Rivera, Manel).

the author responsible for correspondence tasks has been Vera Rivera, Manel.